AAM
CRL icon

Azzad Asset Management’s Charles River Laboratories CRL Stock Holding History

Azzad Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-5,311
Closed -$831K – 335
2025
Q3 		$831K Buy
+5,311
New +$843K 0.08% 257
2023
Q1 		– Sell
-5,607
Closed -$1.22M – 321
2022
Q4 		$1.22M Sell
5,607
-5,263
-48% -$1.15M 0.19% 186
2022
Q3 		$2.02M Hold
10,870
– – 0.2% 165
2022
Q2 		$2.12M Buy
10,870
+5,583
+106% +$1.36M 0.21% 162
2022
Q1 		$1.5M Buy
5,287
+1
+0% +$308 0.22% 181
2021
Q4 		$1.99M Sell
5,286
-27
-0.5% -$10.5K 0.27% 148
2021
Q3 		$2.19M Hold
5,313
– – 0.32% 114
2021
Q2 		$1.97M Sell
5,313
-1
-0% -$334 0.29% 146
2021
Q1 		$1.54M Buy
5,314
+1
+0% +$278 0.26% 161
2020
Q4 		$1.33M Hold
5,313
– – 0.24% 153
2020
Q3 		$1.2M Hold
5,313
– – 0.25% 145
2020
Q2 		$926K Hold
5,313
– – 0.22% 162
2020
Q1 		$671K Sell
5,313
-5,286
-50% -$793K 0.2% 178
2019
Q4 		$1.73M Hold
10,599
– – 0.2% 168
2019
Q3 		$1.63M Buy
10,599
+9,096
+605% +$1.22M 0.2% 172
2019
Q2 		$213K Buy
+1,503
New +$204K 0.06% 287
2019
Q1 		– Sell
-6,438
Closed -$729K – 300
2018
Q4 		$729K Hold
6,438
– – 0.25% 161
2018
Q3 		$866K Hold
6,438
– – 0.23% 167
2018
Q2 		$723K Hold
6,438
– – 0.21% 182
2018
Q1 		$687K Hold
6,438
– – 0.21% 182
2017
Q4 		$705K Hold
6,438
– – 0.22% 163
2017
Q3 		$695K Hold
6,438
– – 0.23% 158
2017
Q2 		$651K Buy
+6,438
New +$593K 0.23% 158

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Azzad Asset Management's CRL Position: Q4 2025 in Review

Azzad Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 5,311 shares — an estimated $831K sold.

Azzad Asset Management first reported a position in CRL in Q2 2017 and held it in 23 quarters. The position peaked at $2.19M in Q3 2021. 581 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

  • Azzad Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
  • Azzad Asset Management sold 5,311 Charles River Laboratories shares in Q4 2025, an estimated $831K.
  • Azzad Asset Management first reported a position in Charles River Laboratories in Q2 2017 and held it in 23 quarters.
  • Azzad Asset Management's Charles River Laboratories position peaked at $2.19M in Q3 2021.
  • 581 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Azzad Asset Management's 13F filing for Q4 2025, filed 21 Jan 2026.